Catyalyst Pharmaceutical (CPRX) to Update on Firdapse Phase 3 at AANEM
Tweet Send to a Friend
Catyalyst Pharmaceutical (NASDAQ: CPRX) announced that safety and efficacy results from its Firdapse™ Phase 3 trial will be presented as ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
